Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Fiat Chrysler and France's Renault could soon partner up to take on the sweeping changes to the global auto industry, according to a report in the Financial Times. The...Autosread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
(Adds details, share price rise)
JOHANNESBURG, May 2 (Reuters) - South African Health and wellness group Ascendis Health said on Thursday it will sell three businesses within its Biosciences division to a consortium for 480 million rand ($33 million) as part of a strategic review.
Ascendis will sell the Efekto, Marltons and Afrikelp businesses to a consortium comprising of RMB Ventures, Nedbank Private Equity and certain members of the management of the Ascendis Biosciences division, it said in a statement.
"Following our strategic business review last year the Biosciences division was considered as non-core to the groups strategy and was identified for sale," Chief Executive Thomas Thomsen said.
"While these Biosciences businesses are performing well, they serve a different set of customers and require capabilities and skills that are not core to Ascendis Health."
Ascendis shares jumped nearly 8 percent after the announcement and closed up 1.58 percent at 4.50 rand.
Efekto manufactures and sells home and garden pesticides, fertiliser and plant food products and Afrikelp specialises in natural growth stimulants extracted from seaweed to improve the quality and quantity of agricultural crops.
Marltons, established over 80 years ago, manufactures and distributes pet care and pet products.
Thomsen said the cash proceeds from the sale will strengthen the group's financial position in the short-term and be used to reduce debt levels and fund working capital.
Ascendis, which also has operations in Cyprus, Hungary, Romania and Spain, said the remaining businesses in the Biosciences division, Avima and Klub M5, may be considered for divestment in the short-to medium-term.
The group has been divesting non-core assets as part of a strategic review aimed at improving cash generation, enhancing profitability and accelerating organic growth.
It announced the sale of its pharmaceutical manufacturing facility in Gauteng for 130 million rand in December. This followed the sale of its South African sports nutrition business for 54 million rand in September.
In January, the group received an unsolicited offer for its Cyprus-based generic pharmaceutical business Remedica. ($1 = 14.5125 rand) (Reporting by Nqobile Dludla; Editing by Alexander Smith)